← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Eisai
-5.62%
Pharma / Pharmaceuticals, Healthcare
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebOverview
Eisai Co., Ltd. is a global pharmaceutical company headquartered in Japan. Founded in 1941, the company focuses on developing, manufacturing, and marketing innovative medicines in several therapeutic areas, including neurology, oncology, and critical care.
Eisai is committed to improving the lives of patients and their families by addressing unmet medical needs and supporting the healthcare system. The company's product portfolio includes treatments for Alzheimer's disease, epilepsy, cancer, and other diseases.
With a presence in over 55 countries, Eisai has a global network of research and development, manufacturing, and marketing facilities. The company collaborates with partners around the world to expand its reach and bring its medicines to those in need.
In addition to its work in developing and commercializing medicines, Eisai also prioritizes corporate responsibility, sustainability, and diversity and inclusion initiatives. The company values the voice of patients and strives to put their interests at the center of everything it does.
Overall, Eisai is committed to making a positive impact on the global healthcare landscape and helping to enhance the quality of life for patients and their families.
Eisai is committed to improving the lives of patients and their families by addressing unmet medical needs and supporting the healthcare system. The company's product portfolio includes treatments for Alzheimer's disease, epilepsy, cancer, and other diseases.
With a presence in over 55 countries, Eisai has a global network of research and development, manufacturing, and marketing facilities. The company collaborates with partners around the world to expand its reach and bring its medicines to those in need.
In addition to its work in developing and commercializing medicines, Eisai also prioritizes corporate responsibility, sustainability, and diversity and inclusion initiatives. The company values the voice of patients and strives to put their interests at the center of everything it does.
Overall, Eisai is committed to making a positive impact on the global healthcare landscape and helping to enhance the quality of life for patients and their families.
What is special about the company?
1. Founder's philosophy: The Eisai company was founded by a Buddhist monk, Dr. Shinobu Eisai, in 1941. He believed in the importance of "human health as the foundation of happiness" and the responsible role of a pharmaceutical company in society.
2. Focus on human health: The company's mission is to "give first thoughts to patients and their families." It prioritizes the needs of patients and aims to provide safe, effective, and affordable medicines.
3. Global presence: Eisai is a multinational company with operations in 55 countries and regions worldwide. It has a strong presence in Japan, the US, and Asia, but also has a growing business in Europe and developing countries.
4. Diverse product portfolio: The company's product portfolio includes a broad range of prescription drugs, over-the-counter medications, and medical devices in various therapeutic areas such as neurology, oncology, and gastrointestinal disorders.
5. Commitment to research and innovation: Eisai invests a significant portion of its revenues in research and development, with a focus on innovative treatments for unmet medical needs. It also collaborates with academic institutions, biotech companies, and other pharmaceutical companies to advance new therapies.
6. Patient support programs: The company offers several patient support programs, such as medication assistance and education programs, to help patients access and understand their medicines.
7. Social and environmental responsibility: Eisai is committed to promoting sustainable practices and environmental conservation. It also supports various social initiatives, such as disaster relief efforts and healthcare access in developing countries.
8. Awards and recognition: The company has received recognition for its efforts in various areas, including patient advocacy, research and development, and corporate social responsibility. Most notably, Eisai was named the most innovative Japanese pharmaceutical company in 2020 by the Forbes Global 2000 list.
9. Corporate culture: The company promotes a supportive and collaborative corporate culture, emphasizing diversity, inclusion, and work-life balance for its employees.
10. Strong financial performance: Eisai has a strong financial track record, with steady revenue growth and profitability. This allows the company to continue investing in research and development and expanding its global presence to serve more patients.
2. Focus on human health: The company's mission is to "give first thoughts to patients and their families." It prioritizes the needs of patients and aims to provide safe, effective, and affordable medicines.
3. Global presence: Eisai is a multinational company with operations in 55 countries and regions worldwide. It has a strong presence in Japan, the US, and Asia, but also has a growing business in Europe and developing countries.
4. Diverse product portfolio: The company's product portfolio includes a broad range of prescription drugs, over-the-counter medications, and medical devices in various therapeutic areas such as neurology, oncology, and gastrointestinal disorders.
5. Commitment to research and innovation: Eisai invests a significant portion of its revenues in research and development, with a focus on innovative treatments for unmet medical needs. It also collaborates with academic institutions, biotech companies, and other pharmaceutical companies to advance new therapies.
6. Patient support programs: The company offers several patient support programs, such as medication assistance and education programs, to help patients access and understand their medicines.
7. Social and environmental responsibility: Eisai is committed to promoting sustainable practices and environmental conservation. It also supports various social initiatives, such as disaster relief efforts and healthcare access in developing countries.
8. Awards and recognition: The company has received recognition for its efforts in various areas, including patient advocacy, research and development, and corporate social responsibility. Most notably, Eisai was named the most innovative Japanese pharmaceutical company in 2020 by the Forbes Global 2000 list.
9. Corporate culture: The company promotes a supportive and collaborative corporate culture, emphasizing diversity, inclusion, and work-life balance for its employees.
10. Strong financial performance: Eisai has a strong financial track record, with steady revenue growth and profitability. This allows the company to continue investing in research and development and expanding its global presence to serve more patients.
What the company's business model?
The Eisai company is a pharmaceutical company focused on discovering, developing, and marketing innovative products for the treatment of various diseases. Their business model is centered around their research and development efforts to create new drugs and therapies, as well as commercializing and promoting their existing products through partnerships and collaborations with other companies.
Eisai's business model also includes a strong focus on patient needs and providing access to their products in underserved areas. They have a global presence and strive to expand their reach to provide healthcare solutions to people around the world.
In addition to their pharmaceutical business, Eisai has also diversified into other areas such as diagnostics, consumer healthcare products, and medical devices. They also invest in digital health technologies and initiatives to improve patient outcomes and healthcare delivery.
Overall, Eisai's business model combines cutting-edge research and development with strategic partnerships, a patient-centric focus, and diversification to ensure a sustainable and successful business in the pharmaceutical industry.
Eisai's business model also includes a strong focus on patient needs and providing access to their products in underserved areas. They have a global presence and strive to expand their reach to provide healthcare solutions to people around the world.
In addition to their pharmaceutical business, Eisai has also diversified into other areas such as diagnostics, consumer healthcare products, and medical devices. They also invest in digital health technologies and initiatives to improve patient outcomes and healthcare delivery.
Overall, Eisai's business model combines cutting-edge research and development with strategic partnerships, a patient-centric focus, and diversification to ensure a sustainable and successful business in the pharmaceutical industry.
Interesting facts about the company
1. One of Eisai’s popular products is the prescription weight loss medication, Belviq® (lorcaserin). It is the first prescription weight loss drug approved by the FDA since 2014.
2. Eisai is the fifth largest pharmaceutical company in Japan and has a strong presence in the global pharmaceutical market.
3. The company was founded in 1941 by Toyoji Naito, who was a naval doctor before starting his own pharmaceutical business.
4. The name Eisai comes from the surname of a famous Japanese monk and philosopher, Eisai Zenji, who is credited with introducing Zen Buddhism to Japan.
5. The company’s research is focused on four main areas: neurology, oncology, gastrointestinal disorders, and integrative medicine.
6. Eisai has a mission to give first thought to patients and their families, and to increasing the benefits that health care provides.
7. In addition to prescription medications, Eisai also produces over-the-counter drugs, diagnostics, and clinical nutraceuticals.
8. Eisai is committed to sustainability and social responsibility, and has been recognized for its efforts in environmental conservation, ethical business practices, and corporate citizenship.
9. The company’s logo, a pair of colorful hands reaching out to form a heart, represents Eisai’s dedication to improving lives and creating harmony in the world.
10. In 2020, Eisai announced a partnership with the Bill & Melinda Gates Foundation to develop a single-dose cure for malaria, which affects millions of people each year in developing countries.
See Company Due Diligence:
2. Eisai is the fifth largest pharmaceutical company in Japan and has a strong presence in the global pharmaceutical market.
3. The company was founded in 1941 by Toyoji Naito, who was a naval doctor before starting his own pharmaceutical business.
4. The name Eisai comes from the surname of a famous Japanese monk and philosopher, Eisai Zenji, who is credited with introducing Zen Buddhism to Japan.
5. The company’s research is focused on four main areas: neurology, oncology, gastrointestinal disorders, and integrative medicine.
6. Eisai has a mission to give first thought to patients and their families, and to increasing the benefits that health care provides.
7. In addition to prescription medications, Eisai also produces over-the-counter drugs, diagnostics, and clinical nutraceuticals.
8. Eisai is committed to sustainability and social responsibility, and has been recognized for its efforts in environmental conservation, ethical business practices, and corporate citizenship.
9. The company’s logo, a pair of colorful hands reaching out to form a heart, represents Eisai’s dedication to improving lives and creating harmony in the world.
10. In 2020, Eisai announced a partnership with the Bill & Melinda Gates Foundation to develop a single-dose cure for malaria, which affects millions of people each year in developing countries.
See Company Due Diligence:
Wait! There's more — sign up for free or log in